Published: Fri, March 10, 2017
Money | By Oscar Reynolds

Investors Catching Stocks: Rite Aid Corporation (NYSE:RAD)

This shows a surprise factor of -75%. Risks related to increased industry consolidation and greater competition can not be ignored.

Vetr upgraded shares of Rite Aid Co. However, Rite Aid's stringent focus on cost management, alongside strengthening its portfolio of health and wellness services has been impressive. "Estimates have been stable ahead of the company's fourth quarter earnings release".

RAD has been the subject of a number of other reports.

Presently Rite Aid Corporation (NYSE:RAD) stock have an ABR of 2.50.

Price Target is basically a projection of future price of a company's stock by the expert analysis of investment analysts or investment firms. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell. Two Sigma Advisers LP now owns 3,308,304 shares of the company's stock worth $25,441,000 after buying an additional 2,431,800 shares during the last quarter.

Just yesterday Rite Aid Corporation (NYSE:RAD) traded -5.69% lower at $5.01.

The price/earnings ratio (P/E) is 60.81 and the forward P/E ratio stands at 54.48. Latest closing price was -31.58% below its 50-day moving average and -36.61% below its 200-day moving average.

Digging a bit further, company shares have been noted -46.81% off the 52 week high and 0.54% away from the 52 week low.

That is until whatever issue that cost Rite Aid Corporation (NYSE:RAD) $2 billion becomes known. During the same period in the prior year, the firm earned $0.06 earnings per share. The Return on Investment (ROI) is at 8.2% while it's Return on Equity (ROE) value stands at 14.9%. The Company has 52-week high of $8.77 and 52-week low of $4.64. Annual EPS Growth of past 5 years is 17.60%. The average revenue estimate for the year ending December 2017 is $1.46B by 21 analysts.

In case of Revenue Estimates, 7 analysts have provided their consensus Average Revenue Estimates for Rite Aid Corporation as 8.25 Billion. This is the current Zacks consensus EPS which was calculated at the time of writing. If you are viewing this report on another domain, it was illegally copied and republished in violation of USA & worldwide copyright law.

Several institutional investors have recently added to or reduced their stakes in the company. Norges Bank purchased a new position in Rite Aid during the fourth quarter worth $61,061,000. For RAD, the company now has $220.03 Million of cash on the books, which is offset by $22.68 Million current liabilities. The average revenue estimate for the year ending February 2017 is $32.56B by 7 analysts.

"As the epidemic continues to grow, as evidenced in the Centers for Disease Control and Prevention recent statistic, 91 people die every day from an opioid overdose in the United States", said Jocelyn Konrad, Rite Aid executive vice president of pharmacy. The RSI (Relative Strength Index), an indicator that shows price strength by comparing upward and downward close-to-close movements is 22.40. Westchester Capital Management LLC purchased a new position in Rite Aid during the second quarter worth $23,459,000. The analysts believe that the company stock price could grow as high as $9. The Company's Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog. The Company's segments include Retail Pharmacy and Pharmacy Services.

Walgreens' revised offer is essentially Rite Aid's market capitalization at the time of Walgreens Boots Alliance (NASDAQ:WBA) buyout offer plus the breakup fee. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia.

Like this: